2022 spells change for EU pharmaceutical legislation
European Pharmaceutical Review
JUNE 24, 2022
It is too early to say because we have not seen the whole package of measures yet. THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION; 2004. One of the key priorities of the EU’s strategy is to encourage innovation to solve unmet medical needs. This obviously presents a huge magnitude of risk for drug developers,” he noted.
Let's personalize your content